Nektar Therapeutics

NAS:NKTRHealthcareCBOEFTSE:MRUTNASDAQ:NCX

$37.20−3.75%LiveIn session · ≈ AED 136.62 · Market cap $1.27B · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	87.3%	75.6%	76.5%	59.3%	68.8%	100.0%	—	—
Operating margin	−248.5%	−437.8%	−261.0%	−152.5%	−106.9%	−236.8%	−236.8%	+0.0 pts
Net margin	−290.6%	−514.0%	−400.0%	−306.3%	−120.9%	−297.1%	−297.1%	+0.0 pts
EBITDA margin	−257.9%	−453.2%	−351.8%	−269.8%	−88.1%	−248.1%	—	—
Return on equity	−41.3%	−77.1%	−100.4%	−210.8%	−195.9%	−182.6%	−182.6%	+0.0 pts
Return on assets	−28.9%	−46.9%	−51.8%	−69.4%	−39.2%	−58.5%	−58.5%	+0.0 pts
Return on capital employed	−26.7%	−43.2%	−37.4%	−39.6%	−43.4%	−57.6%	—	—
Debt / equity	0.1×	0.2×	0.4×	0.9×	1.7×	1.7×	1.7×	+0.0%
Debt / assets	9.8%	12.8%	18.5%	29.6%	33.8%	53.1%	—	—
Interest coverage	−10.2×	−9.4×	−8.3×	−5.4×	−3.7×	−5.0×	—	—
Current ratio	9.8×	9.3×	8.0×	6.5×	4.3×	5.0×	5.0×	+0.0%
Quick ratio	9.7×	9.2×	7.7×	6.1×	4.3×	5.0×	—	—
Cash ratio	1.7×	0.3×	1.3×	0.7×	0.7×	0.3×	0.3×	+0.0%
Asset turnover	0.1×	0.1×	0.1×	0.2×	0.3×	0.2×	—	—
Inventory turnover	1.3×	1.6×	1.1×	2.3×	—	—	—	—
Receivables turnover	3.9×	4.5×	11.0×	40.0×	61.2×	31.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.